Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-07-17 08:46 |
Pharming announces financial results first half year 2009
|
English | 141.3 KB | ||
| 2009-07-14 08:10 |
Pharming provides update on outstanding number of shares
|
English | 67.8 KB | ||
| 2009-06-30 08:06 |
Pharming gives update on outstanding number of shares
|
English | 67.6 KB | ||
| 2009-06-23 08:24 |
Pharming gives update on equity financing with YA Global
|
English | 68.2 KB | ||
| 2009-06-18 08:49 |
Pharming receives government grant to develop human lactoferrin for inflammator…
|
English | 77.0 KB | ||
| 2009-06-17 08:03 |
Pharming announces Euro 9 million debt reduction and continued equity financing…
|
English | 68.9 KB | ||
| 2009-06-09 08:02 |
Pharming provides update on number of outstanding shares
|
English | 67.8 KB | ||
| 2009-06-04 15:11 |
PHARMING RECEIVES AGREEMENT ON PAEDIATRIC INVESTIGATION PLAN FOR RHUCIN® FROM T…
|
English | 68.0 KB | ||
| 2009-06-03 08:37 |
Pharming to present at UBS Global Specialty Pharmaceutical Conference 2009
|
English | 67.4 KB | ||
| 2009-06-01 08:08 |
Interim analysis confirms immunosafety of Rhucin®
|
English | 72.0 KB | ||
| 2009-04-27 15:16 |
Prodarsan® granted Orphan Drug designation from FDA
|
English | 71.2 KB | ||
| 2009-04-17 08:17 |
Pharming announces first quarter 2009 financial results
|
English | 95.3 KB | ||
| 2009-04-16 08:23 |
PHARMING ANNUAL SHAREHOLDER’S MEETING
|
English | 72.0 KB | ||
| 2009-04-15 08:16 |
Pharming secures € 20 million long term Standy Equity Agreement with Yorkville …
|
English | 73.4 KB | ||
| 2009-03-31 12:19 |
Pharming proposes new members for Supervisory Board
|
English | 63.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
